Trial Profile
Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous sulfate; Folic acid
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 22 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Apr 2018.
- 22 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Apr 2018.
- 22 Apr 2017 Status changed from recruiting to active, no longer recruiting.